Skip to main content

Feeding Behavior

0
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
3 programs
Active Implicit PrimingN/A1 trial
Energy StimulusN/A1 trial
Repeated ExposureN/A1 trial
Active Trials
NCT02347527Completed92Est. Aug 2019
NCT04208256Completed63Est. Sep 2024
NCT05639361Unknown180Est. Jun 2024
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Longer meal durationN/A1 trial
Active Trials
NCT03127579Completed50Est. Dec 2017
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Repeated ExposureN/A
Alliance Pharmaceuticals
1 program
School-based water campaignN/A1 trial
Active Trials
NCT02996422Completed1,657Est. Jul 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Colorado TherapeuticsRepeated Exposure
Colorado TherapeuticsEnergy Stimulus
Human BioSciencesLonger meal duration
Alliance PharmaceuticalsSchool-based water campaign
Colorado TherapeuticsActive Implicit Priming

Clinical Trials (5)

Total enrollment: 2,042 patients across 5 trials

NCT05639361Colorado TherapeuticsRepeated Exposure

Healthy Starts: Repeated Exposure Pilot

Start: Apr 2023Est. completion: Jun 2024180 patients
N/AUnknown
NCT04208256Colorado TherapeuticsEnergy Stimulus

Food Intake and the Adolescent Brain

Start: Dec 2019Est. completion: Sep 202463 patients
N/ACompleted
NCT03127579Human BioSciencesLonger meal duration

Family Meal Duration and Children's Eating Behavior

Start: Nov 2016Est. completion: Dec 201750 patients
N/ACompleted
NCT02996422Alliance PharmaceuticalsSchool-based water campaign

Appalachians Together Restoring the Eating Environment: Improving Healthy Diet in Rural Appalachian Kentucky

Start: Nov 2016Est. completion: Jul 20201,657 patients
N/ACompleted
NCT02347527Colorado TherapeuticsActive Implicit Priming

Neuronal and Behavioral Effects of Implicit Priming in Obese Individuals

Start: May 2013Est. completion: Aug 201992 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.